Biodegradable injectable nanoparticles

Details Biodegradable injectable nanoparticles Biodegradable injectable nanoparticles

1993-07-23

1996-08-06

Azpuru, Carlos

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Particulate form

424489, 424497, 424498, 424502, 424451, 424462, 514963, 42840221, 42840224, 428403, A61K 950, A61K 916, A61K 948, A61K 958

Patent

active

055431585

ABSTRACT:
Particles are provided that are not rapidly cleared from the blood stream by the macrophages of the reticuloendothelial system, and that can be modified to achieve variable release rates or to target specific cells or organs. The particles have a biodegradable solid core containing a biologically active material and poly(alkylene glycol) moieties on the surface. The terminal hydroxyl group of the poly(alkylene glycol) can be used to covalently attach onto the surface of the particles biologically active molecules, including antibodies targeted to specific cells or organs, or molecules affecting the charge, lipophilicity or hydrophilicity of the particle. The surface of the particle can also be modified by attaching biodegradable polymers of the same structure as those forming the core of the particles.

REFERENCES:
patent: 4501726 (1985-02-01), Schroder et al.
patent: 4757128 (1988-07-01), Domb et al.
patent: 4789724 (1988-12-01), Domb et al.
patent: 4801739 (1989-01-01), Franz et al.
patent: 4857311 (1989-08-01), Domb et al.
patent: 4888176 (1989-12-01), Langer et al.
patent: 4904479 (1990-02-01), Illum
patent: 5019400 (1991-05-01), Gombotz et al.
patent: 5133908 (1992-07-01), Stainmesse et al.
patent: 5145684 (1992-09-01), Liversidge et al.
patent: 5149543 (1992-09-01), Cohen et al.
patent: 5176907 (1993-01-01), Leong
Agostini, S., "Synthesis and Characterization of PHB," Ph.D. thesis, Case Western University, U.S.A. (1971).
Allen, T. M. and Hansen, C., "Pharmacokinetics of stealth versus conventional liposomes: effect of dose," Biochimica et Biophysica Acta, 1068: 133-141 (1991).
Allen, T. M., et al., "Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo," Biochimica et Biophysica Acta, 1066: 29-36 (1991).
Deng, X. M., et al., J. of Polymer Science: Part C: Polymer Letters, 28: 411-416 (1990).
Illum, L. and Davis, S. S., "The organ uptake of intravenously administered colloidal particles can be altered by using a non-ionic surfactant (Poloxamer 338)," FEBS Lett. 1212, 167(1): 79-82 (1984).
Klibanov, A., et al. "Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target," Biochimica et Biophysica Acta, 1062: 142-148 (1991).
Lasic, D. D., et al., "Sterically stabilized liposomes: a hypothesis on the molecular origin of the extended circulation times." Biochimica et Biophysica Acta, 1070: 187-192 (1991).
Maruyama, K., et al., "Effect of Molecular Weight in Amphipathyic Polyethyleneglycol on Prolonging the Circulation Time of Large Unilamellar Liposomes," Chem. Pharm. Bull., 39(6): 1620-1622 (1991).
Torchilin, V. and Klibanov, A., "The Antibody-Linked Chelating Polymers for Nuclear Therapy And Diagnostics", Critical Reviews in Therapeutic Drug Carrier Systems, 7(4): 275-308 (1991).
Woodle, M. C., et al., "Versatility in lipid compositions showing prolonged circulation with sterically stabilized liposomes."Biochimica et Biophysica Acta, 1105: 193-200 (1992).
Zhu, K. J., et al., "Preparation, Characterization and Properties of Polyactide (PLA)-Poly(ethylene Glycol) (PEG) Copolymers: A Potential Drug Carrier," J. App. Polym. Sci., 39: 1-9 (1990).
Brich, Z., et al., "Branched Ter-Polyesters: Synthesis, Characterization, In Vitro and In Vivo Degradation Behaviour", Proceed. Intern. Symp. Control. Rel. Bioact. Mater. 15:95-96 (1988).
Jedlinski, Zbigniew, et al., "Synthesis of ethylene glycol-L-lactide block copolymers," Makromol. Chem. 194:1681-1689 (1993).

Affiliated with

Also associated with

Rating

Biodegradable injectable nanoparticles does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Biodegradable injectable nanoparticles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biodegradable injectable nanoparticles will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2189463